Friday, July 10, 2026

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 6 of 39
  1. Bacillus Clausii Multi ATB Resist

    Sanofi Pasteur

    Diarrhea, Infantile

    approved small molecule completed

    1 trial
  2. Baricitinib 4 MG

    Chinese University of Hong Kong

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  3. Basiliximab

    The First People's Hospital of Lianyungang

    Safety and Efficacy

    approved small molecule active

    1 trial
  4. Basiliximab,

    The First People's Hospital of Lianyungang

    Beta-Thalassemia Major

    approved small molecule completed

    1 trial
  5. Bavencio 20 mg/mL concentrate for solution for infusion

    Disc Medicine

    urothelial cancer, Bladder cancer, muscle invasive bladder cancer

    approved small molecule active

    1 trial
  6. Beclomethasone (QVAR)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial
  7. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    approved other completed

    2 trials
  8. Behavioral Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved other completed

    1 trial
  9. Behavioral: Buprenorphine/naloxone maintenance (Mtn)

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    approved other completed

    1 trial
  10. Bempedoic Acid / Ezetimibe Oral Tablet

    Esperion Therapeutics

    Cardiovascular Diseases

    approved small molecule active

    1 trial
  11. Bempedoic Acid 180 MG Oral Tablet

    Esperion Therapeutics

    Healthy Lactating Women

    approved small molecule completed

    1 trial
  12. Benlysta 200 mg solution for injection in pre-filled pen.

    GlaxoSmithKline

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial
  13. Berberine

    The First People's Hospital of Lianyungang

    Diabetes Mellitus

    approved small molecule completed

    1 trial
  14. Berberine plus lifestyle intervention

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    approved small molecule completed

    1 trial
  15. Bevacizumab

    Arrowhead Pharmaceuticals Ireland Limited

    Pterygium

    approved small molecule completed

    1 trial
  16. Biktarvy 50 mg/200 mg/25 mg film-coated tablets

    Gilead Sciences Pty Limited

    HIV-1 infection

    approved small molecule active

    1 trial
  17. Bilaxten Flas 10 mg comprimidos bucodispersables

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergic rhinoconjunctivitis

    approved small molecule active

    1 trial
  18. Bimatoprost

    Cardiff Oncology

    Graves' Ophthalmopathy

    approved small molecule completed

    1 trial
  19. BioPhenoT2D

    Fondazione Telethon ETS

    type 2 diabetes

    approved small molecule active

    1 trial
  20. Biomarker

    United Therapeutics Europe Ltd

    Transplantation, Liver

    approved gene therapy terminated

    1 trial
  21. Bismuth-based susceptibility-guided treatment

    Hospital Authority, Hong Kong

    Helicobacter Pylori

    approved small molecule completed

    1 trial
  22. Bisoprolol

    Merck KGaA, Darmstadt, Germany

    Hypertension

    approved small molecule completed

    1 trial
  23. Bisoprolol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    approved small molecule completed

    1 trial
  24. Bleomycin

    BRIGHT MINDS BIOSCIENCES INC.

    Keloid

    approved small molecule active

    1 trial
  25. Blinatumomab

    The First People's Hospital of Lianyungang

    Acute B-cell Lymphoblastic Leukemia

    approved small molecule active

    1 trial
  26. Blood Glucose Meter Systems

    Universal Integrated

    Diabetes

    approved other completed

    1 trial
  27. Bortezomib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Waldenström Macroglobulinemia

    approved small molecule completed

    1 trial
  28. Botulinum Toxin A

    United Therapeutics Europe Ltd

    Low Back Pain

    approved small molecule terminated

    1 trial
  29. Botulinum Toxin Type B

    SUPERNUS PHARMACEUTICALS, INC.

    Cervical Dystonia

    approved mab completed

    1 trial
  30. Brand lamotrigine

    BRIGHT MINDS BIOSCIENCES INC.

    Epilepsy

    approved small molecule completed

    1 trial
  31. Breeze2 glucometer

    Hospital Authority, Hong Kong

    Diabetes

    approved other active

    1 trial
  32. Brentuximab vedotin

    Takeda

    Lymphoma

    approved small molecule active

    2 trials
  33. Brentuximab vedotin

    Takeda

    T-Cell Lymphoma

    approved small molecule completed

    1 trial
  34. Brivudine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Herpes Zoster

    approved small molecule active

    1 trial
  35. Brixadi (Injectable Buprenorphine)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial
  36. Brolucizumab

    The University of Hong Kong

    Age-Related Macular Degeneration

    approved small molecule completed

    1 trial
  37. Brucea javanica oil emulsion injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved other active

    1 trial
  38. Bubble-Enhanced FAST (BEFAST)

    United Therapeutics Europe Ltd

    Abdominal Trauma

    approved small molecule completed

    1 trial
  39. Buccal Buprenorphine 300 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    Analgesia

    approved small molecule active

    1 trial
  40. Budesonide 200 microgram/Puff, HFA MDI

    The First People's Hospital of Lianyungang

    Asthma

    approved small molecule completed

    1 trial
  41. Budesonide-Surfactant

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Premature Infants

    approved small molecule terminated

    1 trial
  42. Bupivacaine

    Hospital Authority, Hong Kong

    Pain

    approved small molecule completed

    1 trial
  43. Bupivacaine

    United Therapeutics Europe Ltd

    Amputation Stumps

    approved small molecule completed

    1 trial
  44. Bupivacaine FNB

    Pacira Ireland Limited

    Pain

    approved small molecule completed

    1 trial
  45. Bupivacaine HCl

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    1 trial
  46. Bupivacaine Hydrochloride

    The First People's Hospital of Lianyungang

    Pulmonary Nodule

    approved small molecule active

    1 trial
  47. Bupivacaine Hydrochloride

    Heron Therapeutics

    Analgesia

    approved small molecule active

    1 trial
  48. Bupivacaine Injection [Marcaine]

    The University of Hong Kong

    Acute Pain

    approved small molecule completed

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.